Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income and revenues:        
Income from purchased receivables $ 6,463   $ 11,895  
Revenue from contracts with customers 25 $ 225 6,050 $ 1,350
Revenue recognized under units-of-revenue method 709 605 1,828 1,575
Total income and revenues 7,197 830 19,773 2,925
Operating expenses:        
Research and development 817 25 2,011 118
General and administrative 8,020 6,368 27,485 18,341
Royalty purchase agreement asset impairment 14,000   23,000 1,575
Arbitration settlement costs       4,132
Amortization of intangible assets   224   673
Total operating expenses 22,837 6,617 52,496 24,839
Loss from operations (15,640) (5,787) (32,723) (21,914)
Other income (expense):        
Gain on the acquisition of Kinnate     19,316  
Change in fair value of embedded derivative related to RPA     8,100  
Interest expense (3,493)   (10,446)  
Other income (expense), net 1,890 278 5,900 1,192
Net loss (17,243) (5,509) (9,853) (20,722)
Net loss attributable to common stockholders, basic (18,611) (6,877) (13,957) (24,826)
Net loss attributable to common stockholders, diluted $ (18,611) $ (6,877) $ (13,957) $ (24,826)
Net loss per share attributable to common stockholders, Basic (in dollars per share) $ (1.59) $ (0.60) $ (1.20) $ (2.17)
Net loss per share attributable to common stockholders, Diluted (in dollars per share) $ (1.59) $ (0.60) $ (1.20) $ (2.17)
Weighted average shares used in computing net loss per share attributable to common stockholders, Basic 11,712 11,473 11,645 11,466
Weighted average shares used in computing net loss per share attributable to common stockholders, Diluted 11,712 11,473 11,645 11,466